查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1812395

马匹医疗保健市场

Equine Healthcare Market
出版日期: | 出版商: Transparency Market Research | 英文 205 Pages | 商品交期: 2-10个工作天内

价格

马匹医疗保健市场-报告范围

TMR 的全球马匹医疗保健市场报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2025 年至 2035 年期间全球马匹医疗保健市场的收入，以 2025 年为基准年，2035 年为预测年。该报告还提供了 2025 年至 2035 年期间全球马匹医疗保健市场的年复合成长率(CAGR %)。

本报告经过广泛的研究后编写。主要研究工作量较大，分析师访问了关键意见领袖、产业领袖和舆论领袖。次要研究则参考了主要厂商的产品资料、年度报告、新闻稿和相关文件，以了解两轮车导航显示器市场。

市场概况
2024年的市场价值 8亿美元
2035年的市场价值 13亿美元
复合年增长率 4.8%

本报告深入探讨了全球两轮车导航显示器市场的竞争格局。该报告确定了全球马匹医疗保健市场的主要参与者，并根据其各项属性对每位参与者进行了分析。本报告涵盖了公司概况、财务状况、近期发展和 SWOT 分析等内容，涵盖了全球马匹医疗保健市场参与者的各项属性。

全球马匹医疗保健市场报告解答的关键问题：

  • 预测期内，所有地区的血液分离术销售额/收入为何？
  • 全球两轮车导航显示器市场有哪些机会？
  • 市场的主要驱动因素、限制因素、机会和威胁是什么？
  • 在预测期内，哪个区域市场将以最快的复合年增长率扩张？
  • 预计哪个领域将在 2035 年创造全球最高收入？
  • 预测期内，哪个细分市场预计以最高复合年增长率扩张？
  • 在全球市场中经营的不同公司的市场地位如何？

马匹医疗保健市场-研究目标和研究方法

这份关于全球马匹医疗保健市场的综合报告首先概述了研究范围和目标。报告详细阐述了本研究的目标、市场中的主要供应商和分销商，以及产品审批的监管情况。

为了方便阅读，本报告采用章节式编排，每个章节又细分为多个小节。报告包含详尽的图表，并适当穿插。各关键细分市场的实际值和预测值以图形方式呈现，视觉上引人入胜。此外，报告也便于读者比较过去和预测期末各关键细分市场的市占率。

本报告从产品、最终用户和地区角度分析了全球马匹保健市场。该报告对每个标准下的关键细分市场进行了深入研究，并提供了2035年底每个细分市场的市场份额。这些宝贵的见解使市场利益相关者能够在全球两轮车导航显示器市场投资时做出明智的商业决策。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概况

  • 介绍
  • 概述
  • 市场动态
  • 2020年至2035年全球马匹医疗保健市场分析与预测

第五章：关键见解

  • 马匹医疗保健市场趋势
  • 主要地区/国家的监管情况
  • PESTEL分析
  • 波特的分析
  • 马用药物和疫苗的管道分析
  • 马匹保健产品的价格趋势
  • 重要行业活动
  • 重点地区/国家流行病学分析
  • 新市场进入者的市场进入策略
  • 最终用户的关键入围指标
  • 对主要竞争对手提供的产品基准化分析

第六章：全球市场分析与预测：依产品类型

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年按产品类型分類的市场价值预测
    • 疗法
      • 药物
        • 抗感染
        • 消炎剂
        • 杀寄生虫剂
        • 其他的
      • 疫苗
        • 灭活
        • 减毒活疫苗
        • 重组
        • 其他的
      • 补充饲料添加剂
        • 蛋白质和胺基酸
        • 维生素
        • 酵素
        • 矿物质
        • 其他的
      • 再生医学
    • 诊断
      • 诊断试剂盒和试剂
      • 仪器
  • 按产品类型分類的市场吸引力

第七章：全球市场分析与预测：按适应症

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年各适应症市场价值预测
    • 马流感
    • 马疱疹病毒（EHV）
    • 马脑脊髓炎
    • 西尼罗病毒
    • 马狂犬病
    • 波托马克马热病
    • 骨关节炎
    • 破伤风
    • 其他的
  • 市场吸引力（依适应症分）

第八章：全球市场分析与预测：按最终用户

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年终端用户市场价值预测
    • 兽医院
    • 马科动物诊所
    • 马术设施
    • 其他的
  • 最终用户的市场吸引力

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各国家的市场吸引力

第十章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 瑞士
  • 荷兰
  • 欧洲其他地区

第 12 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲和纽西兰
  • 亚太其他地区

第十三章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 各公司市占率分析（2024年）
  • 公司简介
    • Zoetis
    • Arthrex, Inc.
    • Dechra Pharmaceuticals
    • Boehringer Ingelheim Animal Health USA Inc.
    • Ceva
    • Heska Corporation
    • Merck & Co., Inc.,
    • Esaote SpA
    • IDEXX
    • Covetrus
    • Elanco
    • Cargill, Incorporated
    • Santa Cruz Biotechnology Inc.
    • Other Prominent Players
Product Code: TMRGL1603

Equine Healthcare Market- Scope of Report

TMR's report on the global Equine Healthcare Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Equine Healthcare Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Equine Healthcare Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Equine Healthcare Market .

Market Snapshot
Market Value in 2024US$ 0.8 Bn
Market Value in 2035US$ 1.3 Bn
CAGR4.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Equine Healthcare Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Equine Healthcare Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Equine Healthcare Market .

The report delves into the competitive landscape of the global Equine Healthcare Market . Key players operating in the global Equine Healthcare Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Equine Healthcare Marketprofiled in this report.

Key Questions Answered in Global Equine Healthcare MarketReport:

  • What are the opportunities in the global Equine Healthcare Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Equine Healthcare Market- Research Objectives and Research Approach

The comprehensive report on the global Equine Healthcare Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Equine Healthcare Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Equine Healthcare Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Equine Healthcare Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Equine Healthcare Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Equine Healthcare Market Trends
  • 5.2. Regulatory Scenario Across Key Regions/Countries
  • 5.3. PESTEL Analysis
  • 5.4. PORTER's Analysis
  • 5.5. Pipeline Analysis for Equine Drugs and Vaccines
  • 5.6. Pricing Trends of Equine Health Care Products
  • 5.7. Key Industry Events
  • 5.8. Epidemiology Analysis Across Key Regions/Countries
  • 5.9. Go-to-Market Strategy for New Market Entrants
  • 5.10. Key Shortlisting Metrics for End-users
  • 5.11. Benchmarking of the Products Offered by the Leading Competitors

6. Global Equine Healthcare Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020 to 2035
    • 6.3.1. Therapeutics
      • 6.3.1.1. Drugs
        • 6.3.1.1.1. Anti-Infective
        • 6.3.1.1.2. Anti-inflammatory
        • 6.3.1.1.3. Parasiticides
        • 6.3.1.1.4. Others
      • 6.3.1.2. Vaccine
        • 6.3.1.2.1. Inactivated
        • 6.3.1.2.2. Live Attenuated
        • 6.3.1.2.3. Recombinant
        • 6.3.1.2.4. Others
      • 6.3.1.3. Supplemental Feed additives
        • 6.3.1.3.1. Proteins and amino acids
        • 6.3.1.3.2. Vitamins
        • 6.3.1.3.3. Enzymes
        • 6.3.1.3.4. Minerals
        • 6.3.1.3.5. Others
      • 6.3.1.4. Regenerative Medicine
    • 6.3.2. Diagnostics
      • 6.3.2.1. Diagnostic Kits & Reagents
      • 6.3.2.2. Instruments
  • 6.4. Market Attractiveness By Product Type

7. Global Equine Healthcare Market Analysis and Forecasts, By Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Indication, 2020 to 2035
    • 7.3.1. Equine Influenza
    • 7.3.2. Equine Herpes virus (EHV)
    • 7.3.3. Equine Encephalomyelitis
    • 7.3.4. West Nile Virus
    • 7.3.5. Equine Rabies
    • 7.3.6. Potomac Horse Fever
    • 7.3.7. Osteoarthritis
    • 7.3.8. Tetanus
    • 7.3.9. Others
  • 7.4. Market Attractiveness By Indication

8. Global Equine Healthcare Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020 to 2035
    • 8.3.1. Veterinary Hospitals
    • 8.3.2. Equine Clinics
    • 8.3.3. Equestrian Facilities
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Equine Healthcare Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Equine Healthcare Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020 to 2035
    • 10.2.1. Therapeutics
      • 10.2.1.1. Drugs
        • 10.2.1.1.1. Anti-Infective
        • 10.2.1.1.2. Anti-inflammatory
        • 10.2.1.1.3. Parasiticides
        • 10.2.1.1.4. Others
      • 10.2.1.2. Vaccine
        • 10.2.1.2.1. Inactivated
        • 10.2.1.2.2. Live Attenuated
        • 10.2.1.2.3. Recombinant
        • 10.2.1.2.4. Others
      • 10.2.1.3. Supplemental Feed additives
        • 10.2.1.3.1. Proteins and amino acids
        • 10.2.1.3.2. Vitamins
        • 10.2.1.3.3. Enzymes
        • 10.2.1.3.4. Minerals
        • 10.2.1.3.5. Others
      • 10.2.1.4. Regenerative Medicine
    • 10.2.2. Diagnostics
      • 10.2.2.1. Diagnostic Kits & Reagents
      • 10.2.2.2. Instruments
  • 10.3. Market Value Forecast By Indication, 2020 to 2035
    • 10.3.1. Equine Influenza
    • 10.3.2. Equine Herpes virus (EHV)
    • 10.3.3. Equine Encephalomyelitis
    • 10.3.4. West Nile Virus
    • 10.3.5. Equine Rabies
    • 10.3.6. Potomac Horse Fever
    • 10.3.7. Osteoarthritis
    • 10.3.8. Tetanus
    • 10.3.9. Others
  • 10.4. Market Value Forecast By End-user, 2020 to 2035
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Equine Clinics
    • 10.4.3. Equestrian Facilities
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Equine Healthcare Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020 to 2035
    • 11.2.1. Therapeutics
      • 11.2.1.1. Drugs
        • 11.2.1.1.1. Anti-Infective
        • 11.2.1.1.2. Anti-inflammatory
        • 11.2.1.1.3. Parasiticides
        • 11.2.1.1.4. Others
      • 11.2.1.2. Vaccine
        • 11.2.1.2.1. Inactivated
        • 11.2.1.2.2. Live Attenuated
        • 11.2.1.2.3. Recombinant
        • 11.2.1.2.4. Others
      • 11.2.1.3. Supplemental Feed additives
        • 11.2.1.3.1. Proteins and amino acids
        • 11.2.1.3.2. Vitamins
        • 11.2.1.3.3. Enzymes
        • 11.2.1.3.4. Minerals
        • 11.2.1.3.5. Others
      • 11.2.1.4. Regenerative Medicine
    • 11.2.2. Diagnostics
      • 11.2.2.1. Diagnostic Kits & Reagents
      • 11.2.2.2. Instruments
  • 11.3. Market Value Forecast By Indication, 2020 to 2035
    • 11.3.1. Equine Influenza
    • 11.3.2. Equine Herpes virus (EHV)
    • 11.3.3. Equine Encephalomyelitis
    • 11.3.4. West Nile Virus
    • 11.3.5. Equine Rabies
    • 11.3.6. Potomac Horse Fever
    • 11.3.7. Osteoarthritis
    • 11.3.8. Tetanus
    • 11.3.9. Others
  • 11.4. Market Value Forecast By End-user, 2020 to 2035
    • 11.4.1. Veterinary Hospitals
    • 11.4.2. Equine Clinics
    • 11.4.3. Equestrian Facilities
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Equine Healthcare Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020 to 2035
    • 12.2.1. Therapeutics
      • 12.2.1.1. Drugs
        • 12.2.1.1.1. Anti-Infective
        • 12.2.1.1.2. Anti-inflammatory
        • 12.2.1.1.3. Parasiticides
        • 12.2.1.1.4. Others
      • 12.2.1.2. Vaccine
        • 12.2.1.2.1. Inactivated
        • 12.2.1.2.2. Live Attenuated
        • 12.2.1.2.3. Recombinant
        • 12.2.1.2.4. Others
      • 12.2.1.3. Supplemental Feed additives
        • 12.2.1.3.1. Proteins and amino acids
        • 12.2.1.3.2. Vitamins
        • 12.2.1.3.3. Enzymes
        • 12.2.1.3.4. Minerals
        • 12.2.1.3.5. Others
      • 12.2.1.4. Regenerative Medicine
    • 12.2.2. Diagnostics
      • 12.2.2.1. Diagnostic Kits & Reagents
      • 12.2.2.2. Instruments
  • 12.3. Market Value Forecast By Indication, 2020 to 2035
    • 12.3.1. Equine Influenza
    • 12.3.2. Equine Herpes virus (EHV)
    • 12.3.3. Equine Encephalomyelitis
    • 12.3.4. West Nile Virus
    • 12.3.5. Equine Rabies
    • 12.3.6. Potomac Horse Fever
    • 12.3.7. Osteoarthritis
    • 12.3.8. Tetanus
    • 12.3.9. Others
  • 12.4. Market Value Forecast By End-user, 2020 to 2035
    • 12.4.1. Veterinary Hospitals
    • 12.4.2. Equine Clinics
    • 12.4.3. Equestrian Facilities
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. South Korea
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Equine Healthcare Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020 to 2035
    • 13.2.1. Therapeutics
      • 13.2.1.1. Drugs
        • 13.2.1.1.1. Anti-Infective
        • 13.2.1.1.2. Anti-inflammatory
        • 13.2.1.1.3. Parasiticides
        • 13.2.1.1.4. Others
      • 13.2.1.2. Vaccine
        • 13.2.1.2.1. Inactivated
        • 13.2.1.2.2. Live Attenuated
        • 13.2.1.2.3. Recombinant
        • 13.2.1.2.4. Others
      • 13.2.1.3. Supplemental Feed additives
        • 13.2.1.3.1. Proteins and amino acids
        • 13.2.1.3.2. Vitamins
        • 13.2.1.3.3. Enzymes
        • 13.2.1.3.4. Minerals
        • 13.2.1.3.5. Others
      • 13.2.1.4. Regenerative Medicine
    • 13.2.2. Diagnostics
      • 13.2.2.1. Diagnostic Kits & Reagents
      • 13.2.2.2. Instruments
  • 13.3. Market Value Forecast By Indication, 2020 to 2035
    • 13.3.1. Equine Influenza
    • 13.3.2. Equine Herpes virus (EHV)
    • 13.3.3. Equine Encephalomyelitis
    • 13.3.4. West Nile Virus
    • 13.3.5. Equine Rabies
    • 13.3.6. Potomac Horse Fever
    • 13.3.7. Osteoarthritis
    • 13.3.8. Tetanus
    • 13.3.9. Others
  • 13.4. Market Value Forecast By End-user, 2020 to 2035
    • 13.4.1. Veterinary Hospitals
    • 13.4.2. Equine Clinics
    • 13.4.3. Equestrian Facilities
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020 to 2035
    • 14.2.1. Therapeutics
      • 14.2.1.1. Drugs
        • 14.2.1.1.1. Anti-Infective
        • 14.2.1.1.2. Anti-inflammatory
        • 14.2.1.1.3. Parasiticides
        • 14.2.1.1.4. Others
      • 14.2.1.2. Vaccine
        • 14.2.1.2.1. Inactivated
        • 14.2.1.2.2. Live Attenuated
        • 14.2.1.2.3. Recombinant
        • 14.2.1.2.4. Others
      • 14.2.1.3. Supplemental Feed additives
        • 14.2.1.3.1. Proteins and amino acids
        • 14.2.1.3.2. Vitamins
        • 14.2.1.3.3. Enzymes
        • 14.2.1.3.4. Minerals
        • 14.2.1.3.5. Others
      • 14.2.1.4. Regenerative Medicine
    • 14.2.2. Diagnostics
      • 14.2.2.1. Diagnostic Kits & Reagents
      • 14.2.2.2. Instruments
  • 14.3. Market Value Forecast By Indication, 2020 to 2035
    • 14.3.1. Equine Influenza
    • 14.3.2. Equine Herpes virus (EHV)
    • 14.3.3. Equine Encephalomyelitis
    • 14.3.4. West Nile Virus
    • 14.3.5. Equine Rabies
    • 14.3.6. Potomac Horse Fever
    • 14.3.7. Osteoarthritis
    • 14.3.8. Tetanus
    • 14.3.9. Others
  • 14.4. Market Value Forecast By End-user, 2020 to 2035
    • 14.4.1. Veterinary Hospitals
    • 14.4.2. Equine Clinics
    • 14.4.3. Equestrian Facilities
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Zoetis
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Arthrex, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Dechra Pharmaceuticals
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Boehringer Ingelheim Animal Health USA Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Ceva
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Heska Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Merck & Co., Inc.,
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Esaote SpA
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. IDEXX
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Covetrus
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Elanco
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Cargill, Incorporated
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Santa Cruz Biotechnology Inc.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Other Prominent Players
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Financial Overview
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
  • Table 03: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035
  • Table 04: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035
  • Table 05: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035
  • Table 06: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
  • Table 07: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Indication, 2020 to 2035
  • Table 08: Global Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 09: Global Equine Healthcare Market Value (US$ Mn) Forecast, By Region, 2020 to 2035
  • Table 10: North America - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 11: North America - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 12: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
  • Table 13: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035
  • Table 14: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035
  • Table 15: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035
  • Table 16: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
  • Table 17: North America - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 18: North America - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 19: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 20: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 21: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
  • Table 22: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035
  • Table 23: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035
  • Table 24: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035
  • Table 25: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
  • Table 26: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 27: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 28: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 29: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 30: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
  • Table 31: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035
  • Table 32: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035
  • Table 33: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035
  • Table 34: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
  • Table 35: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 36: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 37: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 38: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 39: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
  • Table 40: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035
  • Table 41: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035
  • Table 42: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035
  • Table 43: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
  • Table 44: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 45: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 46: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 47: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 48: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Therapeutics, 2020 to 2035
  • Table 49: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Drugs, 2020 to 2035
  • Table 50: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Vaccine, 2020 to 2035
  • Table 51: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Supplemental Feed Additives, 2020 to 2035
  • Table 52: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By Diagnostics, 2020 to 2035
  • Table 53: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 54: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 03: Global Equine Healthcare Market Revenue (US$ Mn), by Therapeutics, 2020 to 2035
  • Figure 04: Global Equine Healthcare Market Revenue (US$ Mn), by Diagnostics, 2020 to 2035
  • Figure 05: Global Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 06: Global Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 07: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Influenza, 2020 to 2035
  • Figure 08: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Herpes virus (EHV), 2020 to 2035
  • Figure 09: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Encephalomyelitis, 2020 to 2035
  • Figure 10: Global Equine Healthcare Market Revenue (US$ Mn), by West Nile Virus, 2020 to 2035
  • Figure 11: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Rabies, 2020 to 2035
  • Figure 12: Global Equine Healthcare Market Revenue (US$ Mn), by Potomac Horse Fever, 2020 to 2035
  • Figure 13: Global Equine Healthcare Market Revenue (US$ Mn), by Osteoarthritis, 2020 to 2035
  • Figure 14: Global Equine Healthcare Market Revenue (US$ Mn), by Tetanus, 2020 to 2035
  • Figure 15: Global Equine Healthcare Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 16: Global Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 17: Global Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 18: Global Equine Healthcare Market Revenue (US$ Mn), by Veterinary Hospitals, 2020 to 2035
  • Figure 19: Global Equine Healthcare Market Revenue (US$ Mn), by Equine Clinics, 2020 to 2035
  • Figure 20: Global Equine Healthcare Market Revenue (US$ Mn), by Equestrian Facilities, 2020 to 2035
  • Figure 21: Global Equine Healthcare Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 22: Global Equine Healthcare Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 23: Global Equine Healthcare Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 24: North America - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 25: North America - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 26: North America - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 27: North America Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 28: North America Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 29: North America - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 30: North America - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 31: North America - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 32: North America - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 33: Europe - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 34: Europe - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 35: Europe - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 36: Europe Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 37: Europe Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 38: Europe - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 39: Europe - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 40: Europe - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 41: Europe - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 42: Asia Pacific - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 43: Asia Pacific - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 44: Asia Pacific - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 45: Asia Pacific Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 46: Asia Pacific Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 47: Asia Pacific - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 48: Asia Pacific - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 49: Asia Pacific - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 50: Asia Pacific - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 51: Latin America - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 52: Latin America - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 53: Latin America - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 54: Latin America Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 55: Latin America Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 56: Latin America - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 57: Latin America - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 58: Latin America - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 59: Latin America - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 60: Middle East & Africa - Equine Healthcare Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 61: Middle East & Africa - Equine Healthcare Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 62: Middle East & Africa - Equine Healthcare Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 63: Middle East & Africa Equine Healthcare Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 64: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 65: Middle East & Africa - Equine Healthcare Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 66: Middle East & Africa - Equine Healthcare Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 67: Middle East & Africa - Equine Healthcare Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 68: Middle East & Africa - Equine Healthcare Market Attractiveness Analysis, By End-user, 2025 to 2035